[go: up one dir, main page]

WO2004011595A3 - Vecteurs destines au transfert de molecules d'interet dans des cellules cibles - Google Patents

Vecteurs destines au transfert de molecules d'interet dans des cellules cibles Download PDF

Info

Publication number
WO2004011595A3
WO2004011595A3 PCT/FR2003/002344 FR0302344W WO2004011595A3 WO 2004011595 A3 WO2004011595 A3 WO 2004011595A3 FR 0302344 W FR0302344 W FR 0302344W WO 2004011595 A3 WO2004011595 A3 WO 2004011595A3
Authority
WO
WIPO (PCT)
Prior art keywords
interest
target cells
vectors
molecules
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2003/002344
Other languages
English (en)
Other versions
WO2004011595A2 (fr
Inventor
Alphonse Garcia
Frederic Dessauge
Veronique Hospital
Gordon Langsley
Santos Susin
Xavier Cayla
Julien Guergnon
Angelita Rebollo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Centre National de la Recherche Scientifique CNRS
Universite Pierre et Marie Curie
Institut National de la Recherche Agronomique INRA
Universite Paris Diderot Paris 7
Institut Pasteur
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Centre National de la Recherche Scientifique CNRS
Universite Pierre et Marie Curie
Institut National de la Recherche Agronomique INRA
Universite Paris Diderot Paris 7
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/FR2002/002705 external-priority patent/WO2003011898A2/fr
Priority claimed from FR0301014A external-priority patent/FR2850396B1/fr
Application filed by Consejo Superior de Investigaciones Cientificas CSIC, Centre National de la Recherche Scientifique CNRS, Universite Pierre et Marie Curie, Institut National de la Recherche Agronomique INRA, Universite Paris Diderot Paris 7, Institut Pasteur filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Priority to AU2003269055A priority Critical patent/AU2003269055A1/en
Publication of WO2004011595A2 publication Critical patent/WO2004011595A2/fr
Anticipated expiration legal-status Critical
Publication of WO2004011595A3 publication Critical patent/WO2004011595A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention se rapporte à de nouveaux vecteurs destinés qu transfert de protéines, d'acides nucléiques ou de toute autre molécule d'intérêt dans des cellules. Cette invention peut être appliquée à des domaines variés, notament pour la délivrance in vivo de médicaments dans des cellules cibles d'un organisme ou le transfert in vitro ou ex vivo de molécules d'intérêt dans des cellules en culture.
PCT/FR2003/002344 2002-07-26 2003-07-24 Vecteurs destines au transfert de molecules d'interet dans des cellules cibles Ceased WO2004011595A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003269055A AU2003269055A1 (en) 2002-07-26 2003-07-24 Vectors for transferring molecules of interest in target cells

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
FR02/02705 2002-03-04
PCT/FR2002/002705 WO2003011898A2 (fr) 2001-07-27 2002-07-26 Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations
FR0301014A FR2850396B1 (fr) 2003-01-29 2003-01-29 Vecteurs destines au transfert de molecules d'interet dans des cellules cibles
FR03/01014 2003-01-29
US48276803P 2003-06-27 2003-06-27
US60/482,768 2003-06-27

Publications (2)

Publication Number Publication Date
WO2004011595A2 WO2004011595A2 (fr) 2004-02-05
WO2004011595A3 true WO2004011595A3 (fr) 2005-08-18

Family

ID=34841418

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2003/002344 Ceased WO2004011595A2 (fr) 2002-07-26 2003-07-24 Vecteurs destines au transfert de molecules d'interet dans des cellules cibles

Country Status (1)

Country Link
WO (1) WO2004011595A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007022534A1 (fr) * 2005-08-19 2007-02-22 Propepgen Biostrategies, Inc. Preparation d'un compose peptidique (norapro-2002) et son utilisation dans l'activation d'enzymes proteines phosphatases-2a
ES2423482T3 (es) 2006-09-08 2013-09-20 Institut Gustave Roussy (Igr) Inhibidores de proteína fosfatasa 1, de GADD34 y del complejo de proteína fosfatasa 1/GADD34, y usos de los mismos combinados con etopósido o mitomicina C
EP2236603A1 (fr) * 2009-03-30 2010-10-06 Universite Pierre Et Marie Curie Peptides pro-apoptotiques
US20130303439A1 (en) 2010-09-30 2013-11-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) Chimeric peptides including a penetrating peptide and a binding domain of pp2a catalytic subunit to caspase-9
CA2859712C (fr) 2011-12-27 2023-09-19 Universite Pierre Et Marie Curie (Paris 6) Peptides de penetration cellulaire
US9364514B2 (en) 2011-12-27 2016-06-14 Institute Curie Anti-tumor adjuvant therapy
CN103788211B (zh) * 2012-11-01 2017-09-01 中国科学院上海药物研究所 双功能肽、所述双功能肽与核酸分子形成的复合物以及治疗肿瘤的药物组合物
FR3000746A1 (fr) * 2013-01-04 2014-07-11 Centre Nat Rech Scient Peptide pour son utilisation dans le traitement des neuronopathies motrices
EP2868326A1 (fr) 2013-11-04 2015-05-06 Université Pierre et Marie Curie (Paris 6) Peptides inhibiteurs de l'interaction TEAD/YAP-TAZ
CA3003156C (fr) 2015-11-06 2023-12-05 Terry Vanden Hoek Peptides et procede de traitement de l'arret cardiaque
US11174322B2 (en) 2017-07-24 2021-11-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Antibodies and peptides to treat HCMV related diseases
US20250163116A1 (en) 2022-03-16 2025-05-22 INSERM (Institut National de la Santé et de la Recherche Médicale) New method to treat infectious diseases

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025945A1 (fr) * 1995-02-21 1996-08-29 Thomas Jefferson University ISOFORMES DE L'ENZYME HUMAINE DE CONVERSION DE L'INTERLEUKINE-1β ET LEURS PROCEDES D'UTILISATION
WO2000069900A2 (fr) * 1999-05-17 2000-11-23 Conjuchem, Inc. Protection de peptides therapeutiques endogenes contre l'activite peptidase par conjugaison de composants sanguins
WO2001015511A2 (fr) * 1999-09-01 2001-03-08 University Of Pittsburgh Of The Commonwealth System Of Higher Education Identification de peptides facilitant l'absorption et le transport cytoplasmique et/ou nucleaire de proteines, d'adn et de virus
WO2001053342A1 (fr) * 2000-01-21 2001-07-26 The Burnham Institute Peptides chimeres de ciblage de la prostate comportant une activite pro-apoptotique
FR2827866A1 (fr) * 2001-07-27 2003-01-31 Pasteur Institut Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025945A1 (fr) * 1995-02-21 1996-08-29 Thomas Jefferson University ISOFORMES DE L'ENZYME HUMAINE DE CONVERSION DE L'INTERLEUKINE-1β ET LEURS PROCEDES D'UTILISATION
WO2000069900A2 (fr) * 1999-05-17 2000-11-23 Conjuchem, Inc. Protection de peptides therapeutiques endogenes contre l'activite peptidase par conjugaison de composants sanguins
WO2001015511A2 (fr) * 1999-09-01 2001-03-08 University Of Pittsburgh Of The Commonwealth System Of Higher Education Identification de peptides facilitant l'absorption et le transport cytoplasmique et/ou nucleaire de proteines, d'adn et de virus
WO2001053342A1 (fr) * 2000-01-21 2001-07-26 The Burnham Institute Peptides chimeres de ciblage de la prostate comportant une activite pro-apoptotique
FR2827866A1 (fr) * 2001-07-27 2003-01-31 Pasteur Institut Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CARTUS T ET AL: "Distribution of protein phosphatases type 1 and 2A in RINm5F cells", REGULATORY PEPTIDES, ELSEVIER SCIENCE BV, NL, vol. 77, no. 1-3, 16 October 1998 (1998-10-16), pages 77 - 81, XP002255404, ISSN: 0167-0115 *
HERICHE J-K ET AL: "Regulation of protein phosphatase 2A by direct interaction with casein kinase 2-alpha", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 276, no. 5314, 1997, pages 952 - 955, XP002255403, ISSN: 0036-8075 *
SARNO S ET AL: "A multifunctional network of basic residues confers unique properties to protein kinase CK2", MOLECULAR AND CELLULAR BIOCHEMISTRY, NORWELL, MA, US, vol. 191, no. 1/2, January 1999 (1999-01-01), pages 13 - 19, XP008022415, ISSN: 0300-8177 *
SHERMAN M P ET AL: "Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 75, no. 3, February 2001 (2001-02-01), pages 1522 - 1532, XP002966101, ISSN: 0022-538X *
SUZUKI T ET AL: "Possible existence of common internalization mechanisms among arginine-rich peptides", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 277, no. 4, 25 January 2002 (2002-01-25), pages 2437 - 2443, XP002963938, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
WO2004011595A2 (fr) 2004-02-05

Similar Documents

Publication Publication Date Title
WO2003020949A3 (fr) Produits de recombinaison cibles d'acides nucleiques et utilisations en rapport avec lesdits produits
EP1808180A3 (fr) GP 100 modifié et ses utilisations
WO2004011595A3 (fr) Vecteurs destines au transfert de molecules d'interet dans des cellules cibles
WO2002077183A9 (fr) Identification de genes essentiels dans des microorganismes
ATE328069T1 (de) Phosphopantethenyltransferasen und deren verwendungen
WO2000014228A8 (fr) Transporteur d'acides amines neutres et gene correspondant
WO2005003296A3 (fr) Proteines hybrides d'albumine
BR0014115A (pt) Métodos de produzir um panto-composto, pantotenato e beta-alanina, de aumentar a produção de um panto-composto e de edentificar compostos que modulam a atividade da pantotenato cinase, microorganismo recombinante, vetor, molécula de ácido nuleico isolada, polipetìdeo e proteìna da pantotenato cinase isolada
MXPA02002384A (es) Polipeptidos similares al factor de crecimiento de fibroblastos.
AU2001265756A1 (en) Sleeping beauty, a transposon vector with a broad host range for the genetic transfprmation in vertebrates
WO2004099387A3 (fr) Silençage genique systemique induit par arnsi dans des systemes mammiferes
WO2001070955A8 (fr) Identification de genes esentiels dans des procaryotes
AU4829999A (en) Methods for rapidly identifying small organic ligands
BRPI0511118A (pt) polipeptìdeos de haemophilus influenzae não transcritos
WO2007047859A3 (fr) Meganucleases conçues rationnellement possedant une specificite sequence modifiee et une affinite de liaison pour l'adn
PL336983A1 (en) Compounds, their production and application as carriers of nucleic acids in cells
WO2008098569A3 (fr) Molécules biologiquement actives, notamment à base de pna et de sirna, procédé permettant leur activation à spécificité cellulaire, et kit d'application pour leur administration
WO2001048209A3 (fr) Genes identifies comme etant requis pour la proliferation de e.coli
WO2011094765A3 (fr) Signal de ciblage pour l'intégration de protéines, peptides et molécules biologiques dans des microcompartiments bactériens
BRPI0410562B8 (pt) proteína de veículo e seu método de produção em uma planta, ácido nucleico isolado, vetor de expressão e célula hospedeira
Meng et al. Enhanced stability of DNA oligonucleotides with partially zwitterionic backbone structures in biological media
BR0014519A (pt) Sequências de sinais para a preparação de leu-herudin através da secreção por e. coli no meio de cultura
BR0213779A (pt) Molécula de ácido nucleico isolada, vetor, célula hospedeira, e, método para a preparação de um composto de quìmica fina
CA2390104A1 (fr) Procede de transfert de substances moleculaires au moyen de proteines procaryotiques liant des acides nucleiques
WO2003029422A3 (fr) Gene du syndrome de noonan

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)